Treatment Details – 8.7 months

Survival: 8.7 months
Toxicity Grade:1
Treatments: Radiation
Hospital:Sir Charles Gairdner Hospital
Date: 7/2004

Patients: This study involved 43 patients with malignant pleural mesothelioma. Only a subset of patients were administered the radiotherapy treatment.

Treatment: The treatment consisted of a single-dose of radiotherapy to prevent the metastasis that often takes place (i.e. 19% of the time) in the chest wall after a thoracoscopy.

Toxicity: Toxicities were described as mild with nothing over grade 1.

Results: There was no statistical difference in metastasis between the patients that received the radiotherapy, and those that did not. The overall median survival was 8.7 months.

Correspondence: Dr. S. Bydder

Get your free copy of
“Surviving Mesothelioma” Today!